These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8251869)

  • 1. Adverse consequences of lysergic acid diethylamide.
    Abraham HD; Aldridge AM
    Addiction; 1993 Oct; 88(10):1327-34. PubMed ID: 8251869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hallucinogen-induced psychological disorders].
    Hermle L; Kovar KA; Hewer W; Ruchsow M
    Fortschr Neurol Psychiatr; 2008 Jun; 76(6):334-42. PubMed ID: 18512184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hallucinogen caused motility disorders in rats as potential psychosis relevant animal model].
    Oelssner W
    Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():53-60. PubMed ID: 7157125
    [No Abstract]   [Full Text] [Related]  

  • 4. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysergic acid diethylamide causes photoreceptor cell damage through inducing inflammatory response and oxidative stress.
    Hu QD; Xu LL; Gong Y; Wu GH; Wang YW; Wu SJ; Zhang Z; Mao W; Zhou YS; Li QB; Yuan JS
    Cutan Ocul Toxicol; 2018 Sep; 37(3):233-239. PubMed ID: 29298533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Synesthesias in the context of hallucinogen-induced persistent perception disorder following the use of lsd].
    Neven A; Blom JD
    Tijdschr Psychiatr; 2014; 56(11):748-52. PubMed ID: 25401683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors.
    Gresch PJ; Strickland LV; Sanders-Bush E
    Neuroscience; 2002; 114(3):707-13. PubMed ID: 12220572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable quantitative EEG difference in post-LSD visual disorder by split-half analysis: evidence for disinhibition.
    Abraham HD; Duffy FH
    Psychiatry Res; 1996 Oct; 67(3):173-87. PubMed ID: 8912957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence on LSD and other hallucinogenic drugs.
    JAMA; 1967 Oct; 202(1):141-4. PubMed ID: 6072003
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute effects of lysergic acid diethylamide (LSD) on resting brain function.
    Müller F; Borgwardt S
    Swiss Med Wkly; 2019 Sep; 149():w20124. PubMed ID: 31568558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
    Arvanov VL; Liang X; Russo A; Wang RY
    Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.
    Titeler M; Lyon RA; Glennon RA
    Psychopharmacology (Berl); 1988; 94(2):213-6. PubMed ID: 3127847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LSD and post-hallucinogen perceptual disorder.
    Madden JS
    Addiction; 1994 Jun; 89(6):762-3. PubMed ID: 7993428
    [No Abstract]   [Full Text] [Related]  

  • 15. ["Flashback": spontaneous psychotic episodes in adolescence resulting from psychedelic drug use].
    Hasse HE; Waldmann H
    Arch Psychiatr Nervenkr (1970); 1971; 214(4):399-439. PubMed ID: 5125222
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features.
    Lerner AG; Gelkopf M; Skladman I; Rudinski D; Nachshon H; Bleich A
    Int Clin Psychopharmacol; 2003 Mar; 18(2):101-5. PubMed ID: 12598822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
    Nichols DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The substance experience, a history of LSD].
    Beck F; Bonnet N
    Med Sci (Paris); 2013 Apr; 29(4):430-3. PubMed ID: 23621940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor.
    McClue SJ; Brazell C; Stahl SM
    Biol Psychiatry; 1989 Jul; 26(3):297-302. PubMed ID: 2742945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling of the interaction of LSD and other hallucinogens with 5-HT2 receptors.
    Westkaemper RB; Glennon RA
    NIDA Res Monogr; 1994; 146():263-83. PubMed ID: 8742803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.